| A comprehensive insight on ocular pharmacokinetics V Agrahari, A Mandal, V Agrahari, HM Trinh, M Joseph, A Ray, H Hadji, ... Drug delivery and translational research 6, 735-754, 2016 | 370 | 2016 |
| MDR-and CYP3A4-mediated drug–herbal interactions D Pal, AK Mitra Life sciences 78 (18), 2131-2145, 2006 | 349 | 2006 |
| Ocular drug delivery: present innovations and future challenges V Gote, S Sikder, J Sicotte, D Pal Journal of Pharmacology and Experimental Therapeutics 370 (3), 602-624, 2019 | 330 | 2019 |
| MDR-and CYP3A4-mediated drug–drug interactions D Pal, AK Mitra Journal of Neuroimmune Pharmacology 1, 323-339, 2006 | 223 | 2006 |
| Ocular delivery of proteins and peptides: Challenges and novel formulation approaches A Mandal, D Pal, V Agrahari, HM Trinh, M Joseph, AK Mitra Advanced drug delivery reviews 126, 67-95, 2018 | 190 | 2018 |
| In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity J Patel, B Buddha, S Dey, D Pal, AK Mitra American journal of therapeutics 11 (4), 262-277, 2004 | 190 | 2004 |
| Novel delivery approaches for cancer therapeutics AK Mitra, V Agrahari, A Mandal, K Cholkar, C Natarajan, S Shah, ... Journal of controlled release 219, 248-268, 2015 | 187 | 2015 |
| Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines S Dey, J Patel, BS Anand, B Jain-Vakkalagadda, P Kaliki, D Pal, ... Investigative ophthalmology & visual science 44 (7), 2909-2918, 2003 | 159 | 2003 |
| Eye: Anatomy, physiology and barriers to drug delivery K Cholkar, SR Dasari, D Pal, AK Mitra Ocular transporters and receptors, 1-36, 2013 | 146 | 2013 |
| Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor S Agarwal, D Pal, AK Mitra International journal of pharmaceutics 339 (1-2), 139-147, 2007 | 134 | 2007 |
| Efflux transporters-and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals D Pal, D Kwatra, M Minocha, DK Paturi, B Budda, AK Mitra Life sciences 88 (21-22), 959-971, 2011 | 130 | 2011 |
| Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor D Aggarwal, D Pal, AK Mitra, IP Kaur International journal of pharmaceutics 338 (1-2), 21-26, 2007 | 123 | 2007 |
| Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes R Krishna Vadlapatla, A Dutt Vadlapudi, D Pal, A K Mitra Current pharmaceutical design 19 (40), 7126-7140, 2013 | 121 | 2013 |
| Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa®) for dry eye disease A Mandal, V Gote, D Pal, A Ogundele, AK Mitra Pharmaceutical research 36, 1-21, 2019 | 118 | 2019 |
| Nanomicellar topical aqueous drop formulation of rapamycin for back-of-the-eye delivery K Cholkar, S Gunda, R Earla, D Pal, AK Mitra AAPS PharmSciTech 16, 610-622, 2015 | 103 | 2015 |
| Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated … M Minocha, V Khurana, B Qin, D Pal, AK Mitra International journal of pharmaceutics 434 (1-2), 306-314, 2012 | 100 | 2012 |
| Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery S Luo, VS Kansara, X Zhu, NK Mandava, D Pal, AK Mitra Molecular pharmaceutics 3 (3), 329-339, 2006 | 92 | 2006 |
| Drug resistance in metastatic breast cancer: tumor targeted nanomedicine to the rescue V Gote, AR Nookala, PK Bolla, D Pal International journal of molecular sciences 22 (9), 4673, 2021 | 91 | 2021 |
| Controlled delivery of ganciclovir to the retina with drug-loaded Poly (d, L-lactide-co-glycolide)(PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal … S Duvvuri, KG Janoria, D Pal, AK Mitra Journal of ocular pharmacology and therapeutics 23 (3), 264-274, 2007 | 90 | 2007 |
| Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib M Minocha, V Khurana, B Qin, D Pal, AK Mitra International journal of pharmaceutics 436 (1-2), 127-134, 2012 | 88 | 2012 |
